IDEAYA Biosciences Inc.

NASDAQ: IDYA · Real-Time Price · USD
24.49
0.12 (0.49%)
At close: Aug 15, 2025, 1:06 PM

IDEAYA Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
7M 23.39M 50.93M 27.94M
Cost of Revenue
n/a 4.01M 2.1M 1.73M
Gross Profit
7M 19.38M 48.83M 26.22M
Operating Income
-326.98M -134.43M -62.5M -50.27M
Interest Income
52.5M 21.47M 3.85M 506K
Pretax Income
-274.48M -112.96M -58.66M -49.76M
Net Income
-274.48M -112.96M -54.81M -47.53M
Selling & General & Admin
39.3M 28.31M 23.9M 20.05M
Research & Development
294.67M 129.51M 89.54M 58.16M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
333.98M 157.81M 113.43M 78.21M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
333.98M 157.81M 113.43M 78.21M
Income Tax Expense
n/a n/a -3.85M -2.23M
Shares Outstanding (Basic)
81.68M 57.52M 41.44M 35.25M
Shares Outstanding (Diluted)
81.68M 57.52M 41.44M 35.25M
EPS (Basic)
-3.36 -1.96 -1.32 -1.35
EPS (Diluted)
-3.36 -1.96 -1.32 -1.35
EBITDA
-326.98M -130.42M -60.4M -48.54M
EBIT
-326.98M -134.43M -62.5M -50.27M
Depreciation & Amortization
n/a 4.01M 2.1M 1.73M